WallStreetZenWallStreetZen

NASDAQ: JAZZ
Jazz Pharmaceuticals PLC Stock Ownership - Who owns Jazz Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Jazz Pharmaceuticals PLC insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Renee D. GalaPresident COO2024-04-051,736$115.21
$200.00kSell
Patricia CarrSVP Chief Accounting Officer2024-03-071,768$116.98
$206.82kSell
Patricia CarrSVP Chief Accounting Officer2024-03-06700$117.51
$82.26kSell
Patricia CarrSVP Chief Accounting Officer2024-03-061,236$120.85
$149.37kSell
Bruce C. CozaddChairman CEO2024-03-0522,436$117.53
$2.64MSell
Neena M. PatilEVP Chief Legal Officer2024-03-053,432$117.53
$403.36kSell
Renee D. GalaPresident COO2024-03-053,622$117.53
$425.69kSell
Samantha PearceSVP Head of Europe Internat2024-03-052,474$117.53
$290.77kSell
Robert IannoneEVP Global Head of RD2024-03-054,294$117.53
$504.67kSell
Philip L. JohnsonEVP Chief Financial Officer2024-03-0112,000$119.65
$1.44MBuy

1 of 4

JAZZ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JAZZ insiders and whales buy or sell their stock.

JAZZ Shareholders

What type of owners hold Jazz Pharmaceuticals PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP49.05%30,583,176$3.35BInsider
Kkr Jp Iii LLC32.21%20,078,838$2.20BInsider
Michael W. Michelson29.79%18,571,250$2.03BInsider
Paul E. Raether29.77%18,557,365$2.03BInsider
Kkr Jp LLC29.77%18,557,365$2.03BInsider
Kkr Group Holdings LP15.95%9,942,946$1.09BInsider
William J. Janetschek13.76%8,577,974$938.95MInsider
Blackrock Inc11.32%7,056,032$772.35MInstitution
Kenneth W. Okeefe10.38%6,468,351$708.03MInsider
Vanguard Group Inc10.21%6,363,748$696.58MInstitution

1 of 3

JAZZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JAZZ26.94%73.06%Net SellingNet Selling
CYTK88.31%11.69%Net SellingNet Selling
PCVX83.78%16.22%Net BuyingNet Buying
EXEL85.28%4.07%Net SellingNet Buying
IONS96.31%3.69%Net SellingNet Selling
View Top Biotech Stocks

Jazz Pharmaceuticals Stock Ownership FAQ

Who owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals (NASDAQ: JAZZ) is owned by 90.03% institutional shareholders, 244.21% Jazz Pharmaceuticals insiders, and 0.00% retail investors. Kkr Group Partnership LP is the largest individual Jazz Pharmaceuticals shareholder, owning 30.58M shares representing 49.05% of the company. Kkr Group Partnership LP's Jazz Pharmaceuticals shares are currently valued at $3.35B.

If you're new to stock investing, here's how to buy Jazz Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.